The past years have established the importance of estrogens in the pathophysiology of
schizophrenia and have shown its relevance to clinical practice through its influence on …

The biochemical integrity of the brain is paramount to the function of the central nervous
system, and oxidative stress is a key contributor to cerebral biochemical impairment …

Atypical antipsychotics (AAP) or second-generation antipsychotics are the clinical option for
schizophrenia treatment during acute psychoses, but they are also indicated for …

Purpose This article aims to evaluate management options for antipsychotic-induced
hyperprolactinemia and associated treatment considerations such as efficacy, tolerability …

Hyperprolactinemia represents a multifaceted endocrine disorder with both physiological
and pathological causes. The increased use of anti-psychotic and anti-depressant …

Background Cognitive impairment is one of the core symptoms of schizophrenia patients.
There are often various differences in the efficacy of different antipsychotics in the treatment …

Objective To evaluate the efficacy and safety of metformin in the treatment of amisulpride-
induced hyperprolactinemia. Methods A total of 86 schizophrenic patients who developed …

Background Antipsychotic drugs are well established to alter serum prolactin levels, often
resulting in adverse effects including amenorrhea, galactorrhea, osteoporosis, and loss of …

The pathophysiological mechanism behind the link between antipsychotic drugs and sexual
dysfunction is still unknown. The goal of this research is to compare the potential effects of …

Background: Schizophrenia, which affects about 0.85% of people worldwide, is the most
common illness among psychotic disorders. Antipsychotic drugs have been a mainstay of …